Kedudukan dalam Saham
#28003
Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the... Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the innovation and commercialization of therapeutic solutions for various kidney-related disorders. The company's primary offering, Sibnayal, targets both distal renal tubular acidosis and cystinuria. Established in 2007, Advicenne S.A. maintains its principal offices in Paris, France.
Harga Saham
$2.00
Disegerakkan terakhir: 2026-08-19
Perubahan (1 tahun)
38.57%
Perdagangan Advicenne S.A. (ALDVI)
Harga ALDVI dengan permodalan pasaran b
Modal pasaran bagi Advicenne S.A.(ALDVI)
Modal Pasaran: $29.13M
Sehingga August 2026, Advicenne S.A. mempunyai modal pasaran sebanyak $29.13M. Ini menjadikan Advicenne S.A. syarikat ke-28003rd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Advicenne S.A. dari 2017 hingga 2026
ALDVI berbanding dengan 5 teratas yang paling popular stocks
| Harga ALDVI |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.301T
|
+18,196,954.09%
|
|
|
|
|
$4.634T
|
+15,907,247.34%
|
|
|
|
|
$4.143T
|
+14,222,107.71%
|
|
|
|
|
$3.589T
|
+12,321,657.57%
|
|
|
|
|
$2.857T
|
+9,807,359.64%
|
